Histologic prognostic markers in stage IIA colorectal cancer: A comparative study

Scandinavian Journal of Gastroenterology

Volumn 51, Issue 3, 2016, Pages 314-320

  Barresi, Valeria ^a   Reggiani Bonetti, Luca ^b   Ieni, Antonio ^a   Branca, Giovanni ^a   Tuccari, Giovanni ^a  

^a UNIVERSITY OF MESSINA   (Italy)

^b UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

Colorectal cancer; D2 40; Disease progression; Lymphatic invasion; PDC; Stage II; Tumour budding

Indexed keywords

ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER RECURRENCE; CANCER STAGING; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL EVALUATION; COHORT ANALYSIS; COLORECTAL CANCER; COMPARATIVE STUDY; DISEASE FREE INTERVAL; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; LYMPHATIC INVASION; MALE; ONCOLOGICAL PARAMETERS; PERINEURAL INVASION; POORLY DIFFERENTIATED CLUSTER; PRIORITY JOURNAL; TUMOR BORDER CONFIGURATION; TUMOR BUDDING; VENOUS INVASION; WORLD HEALTH ORGANIZATION; CANCER GRADING; COLONIC NEOPLASMS; DISEASE COURSE; DISEASE FREE SURVIVAL; LYMPH VESSEL; MIDDLE AGED; OBSERVER VARIATION; PATHOLOGY; PROGNOSIS; RECTAL NEOPLASMS; TUMOR INVASION; TUMOR RECURRENCE; VERY ELDERLY;

AGED; AGED, 80 AND OVER; COLONIC NEOPLASMS; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; HUMANS; LYMPHATIC VESSELS; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; OBSERVER VARIATION; PROGNOSIS; RECTAL NEOPLASMS;

EID: 84946882007     PISSN: 00365521     EISSN: 15027708     Source Type: Journal    
DOI: 10.3109/00365521.2015.1084646     Document Type: Article

References (31)

1. Sobin LH, Gospodarowicz MK, Wittekind C. TNM classification of malignant tumours. 7th ed. New York: Wiley-Blackwell; 2009.
2. Hamilton SR, Bosman FT, Boffetta P, Llyas M, Morreau H, Nakamura SI, et al. Carcinoma of the colon and rectum. In: Bosman T, Carneiro F, Hruban RH, Theise ND, editors. WHO classification of tumours of the digestive system. Lyon: IARC Press; 2010:138-9.
3. Jessup JM, McGinnis LS, Steele GD, Menck HR, Winchester DP. The National Cancer Data Base. Report on colon cancer. Cancer 1996;78:918-26.
4. O'Connell JB, Maggard MA, Ko CY. Colon cancer survival rates with the new American Joint Committee on Cancer sixth edition staging. J Natl Cancer Inst 2004;96:1420-5.
5. La Torre M, Lorenzon L, Pilozzi E, Barucca V, Cavallini M, Ziparo V, et al. Number of harvested lymph nodes is the main prognostic factor in Stage IIa colorectal cancer patients. J Surg Oncol 2012;106:469-74.
6. Santos C, Lopez-Doriga A, Navarro M, Mateo J, Biondo S, Martinez Villacampa M, et al. Clinicopathological risk factors of Stage II colon cancer: results of a prospective study. Colorectal Dis 2013;15:414-22.
7. Hari DM, Leung AM, Lee JH, Sim MS, Vuonq B, Chiu CG, et al. AJCC cancer staging manual 7th edition criteria for colon cancer: do the complex modifications improve prognostic assessment? J Am Coll Surg 2013;217:181-90.
8. Compton C, Fenoglio-Preiser CM, Pettigrew N, Fielding LP. Colorectal Working Group, American Joint Committee on Cancer prognostic factors consensus conference. Cancer 2000;88:1739-57.
9. Akagi Y, Shirouzu K, Kinugasa T. Extramural extension as indicator for postoperative adjuvant chemotherapy in stage IIA (pT3N0) colon cancer. J Surg Oncol 2013;108:358-63.
10. Stocchi L, Fazio VW, Lavery I, Hammel J. Individual surgeon, pathologist, and other factors affecting lymph node harvest in stage II colon carcinoma. Is a minimum of 12 examined lymph nodes sufficient? Ann Surg Oncol 2011;18:405-12.
11. Harris EI, Lewin DN, Wang HL, Lauwers GY, Srivastava A, Shyr Y, et al. Lymphovascular invasion in colorectal cancer: an interobserver variability study. Am J Surg Pathol 2008;32:1816-21.
12. Chandler I, Houlston RS. Interobserver agreement in grading of colorectal cancers-findings from a nationwide web-based survey of histopathologists. Histopathology 2008;52:494-9.
13. Barresi V, Reggiani Bonetti L, Branca G, Di Gregorio C, Ponz de Leon M, Tuccari G. Colorectal carcinoma grading by quantifying poorly differentiated cell clusters is more reproducible and provides more robust prognostic information than conventional grading, Virchows Arch 2012;461:621-8.
14. Ueno H, Kajiwara Y, Shimazaki H, Shinto E, Hashiguchi Y, Nakanishi K, et al. New criteria for histologic grading of colorectal cancer. Am J Surg Pathol 2012;36:193-201.
15. Ueno H, Hase K, Hashiguchi Y, Shimazaki H, Yoshii S, Kudo SE, et al. Novel risk factors for lymph node metastasis in early invasive colorectal cancer: a multi-institution pathology review. J Gastroenterol 2014;49:1314-23.
16. Ueno H, Hase K, Hashiguchi Y, Shimazaki H, Tanaka M, Miyake O, et al. Site-specific tumor grading system in colorectal cancer: multicenter pathologic review of the value of quantifying poorly differentiated clusters. Am J Surg Pathol 2014;38:197-204.
17. Barresi V, Reggiani Bonetti L, Ieni A, Branca G, Baron L, Tuccari G. Histological grading based on the count of poorly differentiated clusters in pre-operative biopsy predicts nodal involvement and pTNM stage in colorectal cancer patients. Hum Pathol 2014;45:268-75.
18. Barresi V, Branca G, Ieni A, Reggiani Bonetti L, Baron L, Mondello S, et al. Poorly differentiated clusters (PDCs) as a novel histological predictor of nodal metastases in pT1 colorectal cancer. Virchows Arch 2014;464:655-62.
19. Barresi V, Reggiani Bonetti L. Correlation between microsatellite instability status and grading assessed by the counting of poorly differentiated clusters in colorectal cancer. Hum Pathol 2015;46:1063.
20. Barresi V, Reggiani Bonetti L, Vitarelli E, Di Gregorio C, Ponz de Leon M, Barresi G. Immunohistochemical assessment of lymphovascular invasion in stage I colorectal carcinoma: prognostic relevance and correlation with nodal micrometastases. Am J Surg Pathol 2012;36:66-72.
21. Ueno H, Mochizuki H, Hashiguchi Y, Shimazaki S, Aida K, Hase, S. Risk factors for an adverse outcome in early invasive colorectal carcinoma. Gastroenterology 2004;127:385-94.
22. National Comprehensive Cancer Network (NCCN) Clinical practice guidelines in oncology (NCCN Guidelines TM). Colon Cancer. Version 2. 2013. Available at http// :www. nccn. org.
23. Saergent D, Sobrero A, Grothey A, O'Connell MJ, Buyse M, Andre T, et al. Evidence for cure by adjuvant therapy in colon cancer: observations based on individual patient data from 20,898 patients on 18 randomized trials. J Clin Oncol 2009;27:872-7.
24. Horcic M, Koelzer VH, Karamitopoulou E, Terracciano L, Puppa G, Zlobec I, Lugli A. Tumor budding score based on 10 high-power fields is a promising basis for a standardized prognostic scoring system in stage II colorectal cancer. Hum Pathol 2013;44:697-705.
25. Iachetta F, Reggiani Bonetti L, Marcheselli L, Di Gregorio C, Cirilli C, Messinese S, et al. Lymph node evaluation in stage IIA colorectal cancer and its impact on patient prognosis: a population-based study. Acta Oncol 2013;52:1682-90.
26. Betge J, Pollheimer MJ, Lindtner RA, Kornprat P, Schlemmer A, Rehak P, et al. Intramural and extramural vascular invasion in colorectal cancer: prognostic significance and quality of pathology reporting. Intramural and extramural vascular invasion in colorectal cancer: prognostic significance and quality of pathology reporting. Cancer 2012;118:628-38.
27. Rosty C, Williamson EJ, Clendenning M, Walters RJ, Win AK, Jenkins MA, et al. Should the grading of colorectal adenocarcinoma include microsatellite instability status? Hum Pathol 2014;45:2077-84.
28. Kalluri R, Weinberg RA. The basics of epithelial-mesenchymal transition. J Clin Invest 2009;119:1420-8.
29. Barresi V, Branca G, Vitarelli E, Tuccari G. Micropapillary pattern and poorly differentiated clusters represent the same biological phenomenon in colorectal cancer: a proposal for a change in terminology. Am J Clin Pathol 2014;142:375-83.
30. Guaita S, Puig I, Franci C, Garrido M, Dominguez D, Batlle E, et al. Snail induction of epithelial to mesenchymal transition in tumor cells is accompanied by MUC1 repression and ZEB1 expression. J Biol Chem 2002;277:39209-16.
31. Barresi V, Reggiani Bonetti L, Ieni A, Caruso RA, Tuccari G. Histological grading in colorectal cancer: new insights and perspectives. Histol Histopathol 2015:11633.